Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 189.26 Million USD | 41.44% |
| 2023 | 133.81 Million USD | 9.4% |
| 2022 | 122.31 Million USD | 21.46% |
| 2021 | 100.7 Million USD | 5.94% |
| 2020 | 95.05 Million USD | 10.54% |
| 2019 | 85.99 Million USD | 13.14% |
| 2018 | 76 Million USD | 3.91% |
| 2017 | 73.14 Million USD | 13.63% |
| 2016 | 64.37 Million USD | 24.75% |
| 2015 | 51.6 Million USD | 0.83% |
| 2014 | 51.17 Million USD | 33.57% |
| 2013 | 38.31 Million USD | 9.5% |
| 2012 | 34.99 Million USD | 9.37% |
| 2011 | 31.99 Million USD | 2.17% |
| 2010 | 31.31 Million USD | -0.15% |
| 2009 | 31.36 Million USD | 12.82% |
| 2008 | 27.79 Million USD | 45.42% |
| 2007 | 19.11 Million USD | 8.45% |
| 2006 | 17.62 Million USD | 27.76% |
| 2005 | 13.79 Million USD | 11.49% |
| 2004 | 12.37 Million USD | 25.75% |
| 2003 | 9.84 Million USD | 13.32% |
| 2002 | 8.68 Million USD | 24.51% |
| 2001 | 6.97 Million USD | 29.32% |
| 2000 | 5.39 Million USD | 22.57% |
| 1999 | 4.4 Million USD | -2.22% |
| 1998 | 4.5 Million USD | 25.0% |
| 1997 | 3.6 Million USD | 5.88% |
| 1996 | 3.4 Million USD | -10.53% |
| 1995 | 3.8 Million USD | 58.33% |
| 1994 | 2.4 Million USD | -4.0% |
| 1993 | 2.5 Million USD | 8.7% |
| 1992 | 2.3 Million USD | -4.17% |
| 1991 | 2.4 Million USD | 9.09% |
| 1990 | 2.2 Million USD | 22.22% |
| 1989 | 1.8 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 160.52 Million USD | 14.1% |
| 2024 FY | 189.26 Million USD | 41.44% |
| 2024 Q4 | 189.26 Million USD | 3.77% |
| 2024 Q3 | 182.39 Million USD | 13.62% |
| 2024 Q1 | 140.69 Million USD | 5.14% |
| 2023 FY | 133.81 Million USD | 9.4% |
| 2023 Q3 | 143.86 Million USD | 5.73% |
| 2023 Q2 | 136.06 Million USD | 5.45% |
| 2023 Q1 | 129.03 Million USD | 5.5% |
| 2023 Q4 | 133.81 Million USD | -6.99% |
| 2022 Q3 | 113.39 Million USD | 5.89% |
| 2022 FY | 122.31 Million USD | 21.46% |
| 2022 Q4 | 122.31 Million USD | 7.86% |
| 2022 Q2 | 107.08 Million USD | 4.87% |
| 2022 Q1 | 102.1 Million USD | 1.4% |
| 2021 Q3 | 99.26 Million USD | 7.28% |
| 2021 Q2 | 92.52 Million USD | -5.17% |
| 2021 FY | 100.7 Million USD | 5.94% |
| 2021 Q1 | 97.57 Million USD | 2.65% |
| 2021 Q4 | 100.7 Million USD | 1.44% |
| 2020 FY | 95.05 Million USD | 10.54% |
| 2020 Q2 | 86.4 Million USD | -1.46% |
| 2020 Q3 | 89.24 Million USD | 3.28% |
| 2020 Q4 | 95.05 Million USD | 6.51% |
| 2020 Q1 | 87.68 Million USD | 1.97% |
| 2019 Q4 | 85.99 Million USD | 1.32% |
| 2019 Q2 | 79.47 Million USD | 0.89% |
| 2019 Q1 | 78.77 Million USD | 3.64% |
| 2019 FY | 85.99 Million USD | 13.14% |
| 2019 Q3 | 84.87 Million USD | 6.79% |
| 2018 Q3 | 77.5 Million USD | 5.15% |
| 2018 Q4 | 76 Million USD | -1.94% |
| 2018 FY | 76 Million USD | 3.91% |
| 2018 Q1 | 73.41 Million USD | 0.37% |
| 2018 Q2 | 73.71 Million USD | 0.41% |
| 2017 Q3 | 75.39 Million USD | 5.18% |
| 2017 Q1 | 69.83 Million USD | 8.49% |
| 2017 FY | 73.14 Million USD | 13.63% |
| 2017 Q2 | 71.68 Million USD | 2.64% |
| 2017 Q4 | 73.14 Million USD | -2.99% |
| 2016 Q2 | 61.48 Million USD | 9.59% |
| 2016 Q1 | 56.1 Million USD | 8.73% |
| 2016 FY | 64.37 Million USD | 24.75% |
| 2016 Q4 | 64.37 Million USD | -1.65% |
| 2016 Q3 | 65.44 Million USD | 6.45% |
| 2015 Q4 | 51.6 Million USD | -6.34% |
| 2015 Q2 | 53.49 Million USD | -2.89% |
| 2015 Q1 | 55.08 Million USD | 7.64% |
| 2015 Q3 | 55.09 Million USD | 2.99% |
| 2015 FY | 51.6 Million USD | 0.83% |
| 2014 Q3 | 51.86 Million USD | 9.57% |
| 2014 Q1 | 43.75 Million USD | 14.2% |
| 2014 FY | 51.17 Million USD | 33.57% |
| 2014 Q2 | 47.33 Million USD | 8.17% |
| 2014 Q4 | 51.17 Million USD | -1.32% |
| 2013 Q3 | 41.08 Million USD | 7.05% |
| 2013 Q4 | 38.31 Million USD | -6.74% |
| 2013 Q2 | 38.37 Million USD | 9.61% |
| 2013 Q1 | 35 Million USD | 0.05% |
| 2013 FY | 38.31 Million USD | 9.5% |
| 2012 Q3 | 36.31 Million USD | -0.31% |
| 2012 Q1 | 34.22 Million USD | 6.96% |
| 2012 Q4 | 34.99 Million USD | -3.64% |
| 2012 FY | 34.99 Million USD | 9.37% |
| 2012 Q2 | 36.42 Million USD | 6.44% |
| 2011 FY | 31.99 Million USD | 2.17% |
| 2011 Q4 | 31.99 Million USD | 1.9% |
| 2011 Q3 | 31.39 Million USD | -0.11% |
| 2011 Q2 | 31.43 Million USD | 4.43% |
| 2011 Q1 | 30.1 Million USD | -3.88% |
| 2010 FY | 31.31 Million USD | -0.15% |
| 2010 Q1 | 30.47 Million USD | -2.84% |
| 2010 Q2 | 30.14 Million USD | -1.06% |
| 2010 Q3 | 31.66 Million USD | 5.03% |
| 2010 Q4 | 31.31 Million USD | -1.11% |
| 2009 Q4 | 31.36 Million USD | -4.58% |
| 2009 FY | 31.36 Million USD | 12.82% |
| 2009 Q1 | 29.95 Million USD | 7.76% |
| 2009 Q3 | 32.86 Million USD | 5.13% |
| 2009 Q2 | 31.26 Million USD | 4.36% |
| 2008 Q4 | 27.79 Million USD | 7.89% |
| 2008 Q2 | 23.14 Million USD | 3.8% |
| 2008 Q1 | 22.29 Million USD | 16.63% |
| 2008 FY | 27.79 Million USD | 45.42% |
| 2008 Q3 | 25.76 Million USD | 11.33% |
| 2007 FY | 19.11 Million USD | 8.45% |
| 2007 Q1 | 17.94 Million USD | 1.8% |
| 2007 Q4 | 19.11 Million USD | 3.64% |
| 2007 Q2 | 18.32 Million USD | 2.13% |
| 2007 Q3 | 18.44 Million USD | 0.65% |
| 2006 Q3 | 17.07 Million USD | 15.04% |
| 2006 FY | 17.62 Million USD | 27.76% |
| 2006 Q4 | 17.62 Million USD | 3.21% |
| 2006 Q2 | 14.84 Million USD | 0.96% |
| 2006 Q1 | 14.7 Million USD | 6.58% |
| 2005 Q1 | 12.38 Million USD | 0.07% |
| 2005 Q2 | 12.36 Million USD | -0.13% |
| 2005 Q3 | 12.79 Million USD | 3.48% |
| 2005 Q4 | 13.79 Million USD | 7.81% |
| 2005 FY | 13.79 Million USD | 11.49% |
| 2004 Q4 | 12.37 Million USD | -0.57% |
| 2004 FY | 12.37 Million USD | 25.75% |
| 2004 Q3 | 12.44 Million USD | 3.67% |
| 2004 Q2 | 12 Million USD | 16.52% |
| 2004 Q1 | 10.3 Million USD | 4.71% |
| 2003 Q4 | 9.84 Million USD | 12.24% |
| 2003 FY | 9.84 Million USD | 13.32% |
| 2003 Q3 | 8.76 Million USD | -3.09% |
| 2003 Q2 | 9.04 Million USD | 1.1% |
| 2003 Q1 | 8.94 Million USD | 3.06% |
| 2002 Q1 | 6.75 Million USD | -3.08% |
| 2002 FY | 8.68 Million USD | 24.51% |
| 2002 Q2 | 6.71 Million USD | -0.67% |
| 2002 Q3 | 6.85 Million USD | 2.13% |
| 2002 Q4 | 8.68 Million USD | 26.63% |
| 2001 Q1 | 5.77 Million USD | 7.16% |
| 2001 Q4 | 6.97 Million USD | 8.07% |
| 2001 Q3 | 6.45 Million USD | 10.38% |
| 2001 Q2 | 5.84 Million USD | 1.16% |
| 2001 FY | 6.97 Million USD | 29.32% |
| 2000 Q1 | 4.2 Million USD | -4.55% |
| 2000 Q4 | 5.39 Million USD | 3.85% |
| 2000 FY | 5.39 Million USD | 22.57% |
| 2000 Q3 | 5.19 Million USD | 15.4% |
| 2000 Q2 | 4.5 Million USD | 7.14% |
| 1999 FY | 4.4 Million USD | -2.22% |
| 1999 Q4 | 4.4 Million USD | -10.2% |
| 1999 Q3 | 4.9 Million USD | -7.55% |
| 1999 Q2 | 5.3 Million USD | 0.0% |
| 1999 Q1 | 5.3 Million USD | 17.78% |
| 1998 Q1 | 3.8 Million USD | 5.56% |
| 1998 Q4 | 4.5 Million USD | 0.0% |
| 1998 Q3 | 4.5 Million USD | 4.65% |
| 1998 Q2 | 4.3 Million USD | 13.16% |
| 1998 FY | 4.5 Million USD | 25.0% |
| 1997 Q1 | 3.4 Million USD | 0.0% |
| 1997 Q4 | 3.6 Million USD | 0.0% |
| 1997 Q3 | 3.6 Million USD | 2.86% |
| 1997 Q2 | 3.5 Million USD | 2.94% |
| 1997 FY | 3.6 Million USD | 5.88% |
| 1996 Q3 | 3.8 Million USD | -5.0% |
| 1996 Q4 | 3.4 Million USD | -10.53% |
| 1996 Q2 | 4 Million USD | 0.0% |
| 1996 FY | 3.4 Million USD | -10.53% |
| 1996 Q1 | 4 Million USD | 5.26% |
| 1995 Q4 | 3.8 Million USD | 0.0% |
| 1995 FY | 3.8 Million USD | 58.33% |
| 1994 Q2 | 2.7 Million USD | 8.0% |
| 1994 FY | 2.4 Million USD | -4.0% |
| 1994 Q4 | 2.4 Million USD | 0.0% |
| 1994 Q1 | 2.5 Million USD | 0.0% |
| 1993 Q1 | 2.6 Million USD | 13.04% |
| 1993 FY | 2.5 Million USD | 8.7% |
| 1993 Q4 | 2.5 Million USD | 0.0% |
| 1992 Q4 | 2.3 Million USD | 0.0% |
| 1992 FY | 2.3 Million USD | -4.17% |
| 1991 FY | 2.4 Million USD | 9.09% |
| 1991 Q4 | 2.4 Million USD | 0.0% |
| 1990 Q4 | 2.2 Million USD | 0.0% |
| 1990 FY | 2.2 Million USD | 22.22% |
| 1989 FY | 1.8 Million USD | 0.0% |
| 1989 Q4 | 1.8 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bionano Genomics, Inc. | 22.89 Million USD | -726.746% |
| Prenetics Global Limited | 3.12 Million USD | -5953.104% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -5434.123% |
| CareDx, Inc | 19.47 Million USD | -872.046% |
| Exact Sciences Corporation | 127.47 Million USD | -48.474% |
| Exagen Inc. | 2.87 Million USD | -6492.372% |
| Inotiv, Inc. | 56.1 Million USD | -237.362% |
| Guardant Health, Inc. | 61.94 Million USD | -205.526% |
| Biodesix, Inc. | 1.4 Million USD | -13419.071% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -16534.909% |
| Precipio, Inc. | 384 Thousand USD | -49188.281% |
| iSpecimen Inc. | - USD | -Infinity% |
| Natera, Inc. | 40.75 Million USD | -364.356% |
| Aspira Women's Health Inc. | 227 Thousand USD | -83277.533% |
| Standard BioTools Inc. | 20.53 Million USD | -821.77% |
| 23andMe Holding Co. | 12.46 Million USD | -1418.387% |
| Castle Biosciences, Inc. | 7.94 Million USD | -2283.115% |
| Personalis, Inc. | 5.66 Million USD | -3243.349% |
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -57248.944% |
| OpGen, Inc. | 1.00 USD | -18926699900.0% |
| T2 Biosystems, Inc. | 4.81 Million USD | -3827.516% |
| Myriad Genetics, Inc. | 20.1 Million USD | -841.627% |
| ICON Public Limited Company | 1.00 USD | -18926699900.0% |
| NeoGenomics, Inc. | 24.15 Million USD | -683.52% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -5434.123% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 50.23% |
| RadNet, Inc. | 1.00 USD | -18926699900.0% |
| MDxHealth SA | 2.77 Million USD | -6710.615% |
| Psychemedics Corporation | 1.00 USD | -18926699900.0% |
| Illumina, Inc. | 587 Million USD | 67.757% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | -490.297% |
| DarioHealth Corp. | 5.06 Million USD | -3638.977% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -3148.104% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -7116.04% |
| OPKO Health, Inc. | 65.69 Million USD | -188.091% |
| Medpace Holdings, Inc. | 1.00 USD | -18926699900.0% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -24241.864% |
| Prenetics Global Limited | 3.12 Million USD | -5953.104% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -30743.429% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -1023850.444% |
| Trinity Biotech plc | 19.93 Million USD | -849.516% |
| Neuronetics, Inc. | 8.09 Million USD | -2238.651% |
| Sotera Health Company | 51.98 Million USD | -264.08% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -1023850.444% |